Evidence map›Paper›PMID 21303251›Full record

ArticleSubstance use & misuse2011

Current and emerging research needs in studying the NYC HIV-drug use epidemic.

Sherry Deren, Holly Hagan, Samuel Friedman, Don C Des Jarlais, David Perlman, Marya Gwadz, Charles Cleland, Andrew Osborne, Joseph Lunievicz

Open access · greenAbstract read
In one paragraph

Article in Substance use & misuse, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sherry DerenCenter for Drug Use and HIV Research, College of Nursing, New York University, New York, New York, USA. shd2@nyu.edu
Holly Hagan
Samuel Friedman
Don C Des Jarlais
David Perlman
Marya Gwadz
Charles Cleland
Andrew Osborne
Joseph Lunievicz
New York University · USNational Development and Research Institutes · USMount Sinai Beth Israel · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Hepatitis Care Coordination in Methadone TreatmentR01DA020841 · NIDA · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI PERLMAN, DAVID C · 2006 to 2010
$1.7M
NIDA NIH HHS P30 DA011041NIDA NIH HHS P30DA011041NIDA NIH HHS R01 DA020841
6 · The paper itself

Abstract

As we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, there are a number of outstanding research questions that remain or are emerging. Following is a summary of some of the topics requiring further research. While this summary does not represent a comprehensive list, it is based on many of the questions raised in the articles in this Special Issue and identifies some of the directions to be investigated during the next decade.

Indexed as

Clinical Trials as TopicEpidemicsHealth Services Needs and DemandHIV InfectionsHIV SeropositivityHumansResearch

Identifiers

PMID21303251
PMCPMC4455883
OpenAlexW2043314491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.